Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).
We analyzed the genetic linkage of nevirapine (NVP) resistance mutations and the genetic complexity of HIV-1 variants in Ugandan infants who were HIV infected despite single dose (SD) prophylaxis. Plasma samples were obtained from six HIV-infected infants who had two or more NVP resistance mutations detected by population sequencing (ViroSeq). ViroSeq PCR products were cloned and transformed, and a single-step amplification-sequencing reaction (AmpliSeq) was used to analyze NVP resistance mutations in cloned HIV-1 variants directly from bacterial colonies. Fifty clones were analyzed for each infant sample. This analysis revealed numerous NVP resistance mutations not detected by population sequencing, genetically linked NVP resistance mutations, and a high degree of genetic complexity at codons that influence NVP susceptibility.
Towler
William Ian
WI
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Church
Jessica D
JD
Eshleman
James R
JR
Fowler
Mary Glenn
MG
Guay
Laura A
LA
Jackson
J Brooks
JB
Eshleman
Susan H
SH
D019943:Amino Acid Substitution / Q000235:genetics; D019380:Anti-HIV Agents / Q000494:pharmacology*; D004252:DNA Mutational Analysis; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D019829:Nevirapine / Q000494:pharmacology*; D010949:Plasma / Q000821:virology; D012367:RNA, Viral / Q000235:genetics; D017422:Sequence Analysis, DNA / Q000379:methods; D014454:Uganda
D019380:Anti-HIV Agents; D012367:RNA, Viral; D019829:Nevirapine
Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S56-63
17825651
Nucleic Acids Res. 2007;35(13):e91
17576693
Clin Chem. 2005 Jan;51(1):35-9
15514094
J Clin Microbiol. 2004 Aug;42(8):3670-4
15297515
J Clin Microbiol. 2005 Jan;43(1):406-13
15635002
Lancet. 2003 Sep 13;362(9387):859-68
13678973
Biotechniques. 2003 Sep;35(3):614-8, 620, 622
14513567
Antimicrob Agents Chemother. 2006 Jan;50(1):351-4
16377709
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7094-9
16641095
J Infect Dis. 2007 Mar 1;195(5):711-5
17262714
Lancet. 1999 Sep 4;354(9181):795-802
10485720
Nat Methods. 2007 Feb;4(2):123-5
17206150
J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):291-6
18167645